AI-generated summary
The authors studied 48 eyes of 48 patients with meibomian gland dysfunction treated with three sessions of intense pulsed light over about 30 days, followed up to day 120. They report improvement in symptom scores and some clinical signs, and associate age, disease severity, baseline Schirmer I test and baseline symptom score with treatment response. Moderate disease severity was linked to a higher chance of effective treatment compared with severe disease.
- Participants
- 48
- Who or what was studied
- 48 patients (48 eyes) with meibomian gland dysfunction
- Limits stated in the abstract
- The abstract does not describe a control group, and the influencing-factor findings come from univariate and logistic regression analyses in a small sample.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.